SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 28, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed27d 17h ago
Insider cluster: 2 insiders, $645K total
Actionable Insight • Neutral

Monitor for any 10b5-1 plan adoption or additional insider sales. The cluster is small and routine; no immediate catalyst is indicated.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
RVMD ▼ -2.25% at T+5d
NEUTRAL call -2.25% · α vs SPY -4.20% · entry $204.48 → $199.87
Next anchor: T+20d due 3h ago
Latest observation: T+18 -6.98% FF3 residual α
Entry = T+0 close
Sep 28, 2026
via day close
T+1d
+0.38%
call +0.38% · α +0.59%
$205.26
settled 27d ago
T+5d
-2.25%
call -2.25% · α -4.20%
$199.87
settled 21d ago
T+20d
Pending
due 3h ago
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

Two insiders at Revolution Medicines sold a total of $645K in stock over a week. Director Elizabeth Anderson exercised and sold shares from a derivative grant, while officer Anthony Mancini sold $626K worth. The sales are modest relative to the company's market cap and appear to be routine portfolio management, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$645.0K
Insiders
2

Key Facts

  • Director Elizabeth Anderson exercised 5,070 shares at $1.12 and sold 10,043 shares at ~$192-$195, netting ~$1.96M in proceeds.
  • Officer Anthony Mancini sold 3,100 shares at $200.54 for $626K.
  • Total open-market sales: ~$2.59M, but only $645K is within the 7-day cluster window.
  • Anderson's sales follow derivative exercises, indicating tax or liquidity planning, not a directional bet.
  • Mancini's single sale is modest and lacks a 10b5-1 plan indication but is not large enough to be material.

Financial Impact

Total insider sales of ~$645K in the cluster window, representing less than 0.1% of market cap.

dilutioninsider sentiment

Risk Factors

  • Insider sales could accelerate if the stock continues to rise, but current activity is not alarming.
  • No material negative news is suggested by these trades.

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RVMD-1790632865892
36 reports for RVMD
Performance horizon
70% Hit rate @ T+60 7 of 10 directional calls Went positive at some point 15 of 17 best @ T+60▲ +31.56%Apr 21, 2026
Filters
Rows
Reports for RVMD — sortable, filterable
TypeNow
Oct 23, 2026
2d ago
Institutional Cluster
BULLISH ★ 4/10
$187.53awaiting T+60—$185.59 (−1.03%)
Oct 21, 2026
4d ago
Press Release
NEUTRAL ★ 1/10
$187.69awaiting T+60—$185.59 (−1.12%)
Oct 13, 2026
12d ago
8-K
BULLISH ★ 6/10
$193.52awaiting T+60—$185.59 (−4.10%)
Oct 12, 2026
14d ago
Institutional Cluster
BULLISH ★ 4/10
$193.95awaiting T+60—$185.59 (−4.31%)
Oct 1, 2026
24d ago
Insider Cluster
NEUTRAL ★ 4/10
$206.64awaiting T+60—$185.59 (−10.19%)
Sep 29, 2026
26d ago
Insider Cluster
NEUTRAL ★ 3/10
$205.26awaiting T+60—$185.59 (−9.58%)
Sep 28, 2026
27d ago
Insider Cluster
NEUTRAL ★ 3/10
$204.48awaiting T+60—$185.59 (−9.24%)
Sep 24, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$204.97awaiting T+60—$185.59 (+9.46%)
Sep 22, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$190.74awaiting T+60—$185.59 (+2.70%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$192.76awaiting T+60—$185.59 (+3.72%)
Showing 10 of 36

US Market Status

Market Open — Closes in 4h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 28, 2026